Do you or did you have any family members who have been diagnosed with MS? Yes No I Don t Know. Yes identical Yes not identical No

Similar documents
Multiple Sclerosis , The Patient Education Institute, Inc. nr Last reviewed: 04/17/2017 1

Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Biologics and Beyond: Treatment of Multiple Sclerosis. Rita Jebrin, PharmD, BCPS

Advances in the Management of Multiple Sclerosis: A closer look at novel therapies. Disclosures

The Impact of Multiple Sclerosis in the. James Bowen, MD Multiple Sclerosis Center

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

APPENDIX D SASKATCHEWAN MS DRUGS PROGRAM

What is Multiple Sclerosis? Gener al information

Anticipated Launches Q Q1 2019

Multiple Sclerosis. What types of MS are there? 4 There are 4 types of MS.

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

Le Hua, MD. Disclosures Teaching and Speaking: Teva Neurosciences, Genzyme, Novartis Advisory Board: Genzyme, EMD Serono

Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA

Page 1. Multiple Sclerosis. I have no conflicts of interest. Team Menstrual Cycles Waves to Wine for MS. Overview.

Pediatric MS treatments: What do you start with, when do you switch?

NEW PATIENT FORM UPMC Neurology Department Drs. Heyman, Zaydan, Xia, and Mr. Ryan Orie

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical Policy: Natalizumab (Tysabri) Reference Number: CP.PHAR.259 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

Current Enrolling Clinical Trials

Clinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011

Multiple Sclerosis Treatment Center of Dallas Annette Okai, MD NEW PATIENT INFORMATION

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada

Clinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.PHAR.258 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

MRN# Provider: Appt. Date: Appt. Time:

Multiple Sclerosis Update

Clinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.CPA.334 Effective Date: Last Review Date: Line of Business: Commercial

Mercy MS Center New Patient Information

Circle Yes or No Y N. [If no, skip to question 8.] 2. Has the patient been compliant with therapy as verified by the prescriber?

Pre-Return Visit Questionnaire for Multiple Sclerosis

Choices. Disease modifying treatments. Read me

See Important Reminder at the end of this policy for important regulatory and legal information.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Clinical Policy: Natalizumab (Tysabri) Reference Number: CP.PHAR.259 Effective Date: Last Review Date: Line of Business: Medicaid

Disclosures 6/26/2015

Treating MS. New medicines, strong evidence, better practice? September 2015

Updates to the Alberta Human Services Drug Benefit Supplement

While MS sometimes causes severe disability, it is only rarely fatal and most people with MS have a normal life expectancy.

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

MRI Spine - FAX Evaluate Neck/Back pain

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Pharmacy Prior Authorization

Immune Modulating Drugs Prior Authorization Request Form

Before beginning this activity, please be sure to review the learning objectives and faculty disclosures.

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Originally published December 2, Revisions and re-print November 2012.

Horizon Scanning Centre July Ocrelizumab for relapsing-remitting multiple sclerosis SUMMARY NIHR HSC ID: 3711

NARCOMS Tremor and Ataxia Questionnaire

Class Update with New Drug Evaluation: Disease-Modifying Drugs for Multiple Sclerosis

Prior Authorization. Drug Name (select from list of drugs shown) Gilenya (fingolomid) Quantity Frequency Strength. Physician Name:

DISEASE-MODIFYING THERAPIES FOR MS

Mellen Center Approaches: Natalizumab

Carolyn Taylor, M.D. Swedish Neuroscience Center

CONSULTATION ADMITTANCE FORM

Multiple sclerosis. Tünde Csépány MD. PhD. 08. November 2017.

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

TREATING MULTIPLE SCLEROSIS The Current Disease Modifying Therapies Beverly Gilder, M.D. Blue Sky Neurology MS Center

ABOUT YOU (Please print clearly) Name Birth Date Age Sex: Male Female Referring MD Mailing Address: Address

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Objectives. There Aren t Enough Hours in the Day

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis(review)

A Glimpse at Immunomodulators in MS

PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day

Multiple sclerosis. Tünde Csépány MD. PhD

Academy Asthma, Allergy, & Sinus Center

Multiple Sclerosis: More Than Your ABC s. Technician Objectives. Pharmacist Objectives. Pretest Question. Pretest Question 9/22/16

Pharmacotherapy Update Multiple Sclerosis

Disease-modifying therapies

Overview 12/8/2008. Simplifying Neurology for critical illness claims. Multiple Sclerosis. Basics Advances in diagnosis and treatment.

History of Present Condition

Pharmacy Management Drug Policy

Welcome to today s webinar: Learn about MS

LIST RESTRICTED ACTIVITY: CURRENT ACTIVITY LEVEL USUAL ACTIVITY LEVEL

MULTI-SYSTEMIC INFECTIOUS DISEASE SYNDROME SYMPTOM QUESTIONNAIRE

Understanding your Tecfidera. treatment. Information for patients who have been prescribed treatment with Tecfidera.

Depression management: Emotional Disorders in Multiple Sclerosis

Prof. Dimitrios Karussis Director of the Hadassah Center for MS

Treatment Algorithm for Multiple Sclerosis Disease-modifying Therapies

HISTORY OF PRESENT ILLNESS A. TELL US ABOUT YOUR PAIN PROBLEM

Fingolimod (Gilenya) What is fingolimod? Can I have this drug?

BRAIN STEM CASE HISTORIES CASE HISTORY VII

Table e-1: Patient Level Baseline Characteristics

Eastern Shore MediCann Clinic, LLC

Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications

Subject: Natalizumab (Tysabri ) IV

GILENYA (fingolimod) oral capsule

CHIROPRACTIC NEW PATIENT HEALTH HISTORY

Pharmacy Name/Location/Phone number:

CDEC FINAL RECOMMENDATION

Please be sure to check with your insurance company to make sure that Dr. Kohli is covered under your plan.

Headache Follow-up Visit Form

Alemtuzumab (Lemtrada)

A Case Study: Multiple Sclerosis. Kayla Jensen February 2013

Transcription:

The following survey will ask you questions about your family history of MS, your MS diagnosis and history, your symptoms, and your treatments. You may find it easier to fully answer these questions if you have your records on hand. Note: This PDF version is for your information only and does not accurately reflect the order of the questions. To view the questions as they are meant to be asked, you must complete the online survey. MS Family History Do you or did you have any family members who have been diagnosed with MS? I Don t Know Please list each family member who has been diagnosed with MS: Family member Mother Father Sister Brother Your twin? identical not identical Your twin? identical not identical Grandmother Maternal side / Grandfather Maternal side / Great- grandmother Maternal side / Great- grandfather Maternal side / Aunt Maternal side / Uncle Maternal side / Cousin male Maternal side / Cousin female Maternal side / Blood relative? Indicate yes, no, or don t know Date of birth (month / day / year or don t know )

Niece Maternal side / Nephew Maternal side / Daughter Son Granddaughter Daughter s side / Son s side Grandson Daughter s side / Son s side Other Maternal side / MS Clinical History Have you ever been diagnosed with multiple sclerosis by a neurologist or other physician? I m not sure If yes If no If I m not sure If no or I m not sure When were you diagnosed with multiple sclerosis by a neurologist or other physician? What tests were performed as part of the diagnostic process? Check all that apply. MRI of your head MRI of your spinal cord Test of your spinal fluid (lumbar puncture/spinal tap) Blood tests Evoked potentials Are you confident that your MS diagnosis is correct? ; I have received a new diagnosis that indicates I do not have MS. New diagnosis: ; I have questions about whether I actually have MS. The following questions will ask about your MS history and symptoms. We understand that your diagnosis has changed; however, it is extremely helpful to learn more about your experiences leading up to this new diagnosis. Please answer to the best of your ability. / The following questions will ask about your MS history and symptoms. We understand that you are unsure of your diagnosis and have questions; however, it is still extremely helpful to learn more about your experience to date. Please answer to the best of your ability. Please elaborate: I have not been diagnosed, but I believe I have MS.

I have not been diagnosed, and I m not sure whether I have MS or not. I have not been diagnosed, and I do not believe I have MS. Please elaborate I am not sure if I have received a diagnosis, but I believe I have MS. I am not sure if I have received a diagnosis, and I m not sure whether I have MS or not. I am not sure if I have received a diagnosis, and I do not believe I have MS. Are you in the process of being tested to find out if you have MS? Have you experienced symptoms that led you to believe you have MS? Have your symptoms ever met the definition of an MS relapse or exacerbation? A relapse or exacerbation is defined as a development of new symptoms or worsening of old symptoms that lasts longer than 48 hours. * In a relapse or exacerbation, MS symptoms generally worsen over a period of days to several weeks. * They then improve partially or completely over several weeks or months. * A relapse or exacerbation can be associated with several different symptoms getting worse at the same time. * Symptoms that occur in the context of an infection or fever do not meet our definition of a relapse or exacerbation. Use the table below to list the exacerbations you experienced prior to diagnosis and up through the first two years following your diagnosis, starting with your first exacerbation. Only list exacerbations you can recall with great accuracy. Date of onset Symptoms (check all that apply) Degree of recovery Vision Weakness Balance Sensory Other See list below

I have not had any exacerbations. Degree of recovery: I made a nearly complete recovery (> 90%): Following recovery from this relapse, I had minimal remaining MS related symptoms or problems that did not already exist prior to the relapse. I made a partial recovery (50-90%): Following recovery from this relapse, I had moderate persistence of MS related symptoms or problems that did not already exist prior to the relapse. I made very little recovery (10-49%): Following recovery from this relapse, I had significant persistence of MS related symptoms or problems that did not already exist prior to the relapse. I made no significant recovery (<10%) from this relapse. I am unable to recall my recovery from this relapse. Have you developed symptoms that have gotten progressively worse over time? Indicate which of the following symptoms have led you to believe that you might have MS. Please tell us if : You have ever experienced this symptom. This symptom occurred during your first exacerbation or at onset. You are currently experiencing this symptom. You have never experienced this symptom. You do not recall whether or not you have experienced this symptom. Check all that apply. Symptom Ever First Currently Never Don t Recall Weakness in arms/hands Weakness in legs/feet Difficulty walking / dragging a foot Loss of coordination in arms / hands Loss of coordination in legs / feet Stiffness / spasms Difficulty with balance Shaking or tremors Paralysis of half or whole face (i.e. facial drooping with altered smile, difficulty closing an eye tightly or wrinkling forehead) Facial twitching Speech articulation (speech sounds slurred

or slowed or loses normal rhythm) Difficulty with swallowing Blindness or blurry vision in one eye or both Disturbed vision e.g. double vision, objects moving, etc. Sensory symptoms: Loss of feeling, painful feeling, unable to feel position of fingers/arms/legs, swollen feeling, numbness, tingling, feeling of pinpricks Vertigo Sharp, painful feeling in face not due to trauma or injury (trigeminal neuralgia) Electric shock- like feeling when bending neck Itching, not due to other causes e.g. psoriasis, insect bites, etc. Burning sensation in feet Cognitive difficulties, e.g. memory problems Sexual dysfunction, not caused by medication Urinary problems, e.g. unusual urgency or hesitancy Trouble with bowel movements Fatigue Changes in mood or depression considered out of the ordinary Total paralysis of legs Total paralysis of arms Need for mechanical ventilation Other: Have you had an MRI that shows evidence that you may have MS? Which of the following best characterizes your form of MS? (check one) Note: A relapse or exacerbation is defined as a development of new symptoms or worsening of old symptoms that lasts longer than 48 hours. * In a relapse or exacerbation, MS symptoms generally worsen over a period of days to several weeks. * They then improve partially or completely over several weeks or months. * A relapse or exacerbation can be associated with several different symptoms getting worse at the same time. * Symptoms that occur in the context of an infection or fever do not meet our definition of a relapse or exacerbation.

Clinically isolated syndrome (CIS) - You have experienced only one exacerbation with or without significant recovery. Relapsing remitting (RRMS) - You have experienced two or more exacerbations, separated by more than 30 days, of being worse for a period of time followed by an improvement in condition. In between exacerbations your MS is stable. Secondary progressive (SPMS) - Your disease began with at least one exacerbation (usually more) separated or followed by periods of stability and has changed to the point where symptoms have been getting progressively worse even when not having an exacerbation. At what age did this change take place? You may answer approximately. years old Primary progressive (PPMS) - Your initial MS symptoms came on too slowly to be considered an exacerbation. Since then, your symptoms have continued to steadily get worse. You may also have experienced one or more exacerbations after onset, or you may never have had an exacerbation. Have you ever had any MS exacerbations that meet the definition above? Don't know Radiologically isolated syndrome (RIS) - Your MRI shows evidence that you may have MS, but you have not had any symptoms that are typical of MS (for instance, a doctor obtained an MRI scan for a reason other than MS and found abnormalities that look like MS). t sure/don t know We re interested in your early experiences with MS. Use the table below to list the exacerbations you experienced prior to diagnosis and up through the first two years following your diagnosis, starting with your first exacerbation. Only list exacerbations you can recall with great accuracy. Date of onset Symptoms (check all that apply) I have not had any exacerbations. Degree of recovery Vision Weakness Balance Sensory Other See list below

Degree of recovery: I made a nearly complete recovery (> 90%): Following recovery from this relapse, I had minimal remaining MS related symptoms or problems that did not already exist prior to the relapse. I made a partial recovery (50-90%): Following recovery from this relapse, I had moderate persistence of MS related symptoms or problems that did not already exist prior to the relapse. I made very little recovery (10-49%): Following recovery from this relapse, I had significant persistence of MS related symptoms or problems that did not already exist prior to the relapse. I made no significant recovery (<10%) from this relapse. I am unable to recall my recovery from this relapse. We're interested in your more recent experiences with MS. Use the table below to list any additional exacerbations you experienced in the last two years. Only list exacerbations you can recall with great accuracy. (Please enter the date in MM/YYYY format) Date of onset Symptoms (check all that apply) Vision Weakness Balance Sensory Other Degree of recovery See list above I have not had any exacerbations in the last two years. Before your first exacerbation or diagnosis, did you experience any symptoms that you feel were due to MS but did not meet the definition of a relapse or a doctor did not consider these symptoms consistent with MS? I Don't know t applicable How old were you when you had your first symptom? You may answer approximately. years old Indicate which of the following symptoms you have experienced as a result of your MS. Please tell us if : You have ever experienced this symptom. This symptom occurred during your first exacerbation or at onset. You are currently experiencing this symptom. You have never experienced this symptom. You do not recall whether or not you have experienced this symptom.

Check all that apply. Symptom Ever First Currently Never Don t Recall Weakness in arms/hands Weakness in legs/feet Difficulty walking / dragging a foot Loss of coordination in arms / hands Loss of coordination in legs / feet Stiffness / spasms Difficulty with balance Shaking or tremors Paralysis of half or whole face (i.e. facial drooping with altered smile, difficulty closing an eye tightly or wrinkling forehead) Facial twitching Speech articulation (speech sounds slurred or slowed or loses normal rhythm) Difficulty with swallowing Blindness or blurry vision in one eye or both Disturbed vision e.g. double vision, objects moving, etc. Sensory symptoms: Loss of feeling, painful feeling, unable to feel position of fingers/arms/legs, swollen feeling, numbness, tingling, feeling of pinpricks Vertigo Sharp, painful feeling in face not due to trauma or injury (trigeminal neuralgia) Electric shock- like feeling when bending neck Itching, not due to other causes e.g. psoriasis, insect bites, etc. Burning sensation in feet Cognitive difficulties, e.g. memory problems Sexual dysfunction, not caused by medication Urinary problems, e.g. unusual urgency or hesitancy Trouble with bowel movements Fatigue Changes in mood or depression considered out of the ordinary Total paralysis of legs Total paralysis of arms Need for mechanical ventilation Other:

Are you currently or have you ever been on any of these therapies to manage your MS or prevent disease activity? Note: Do not check Yes if you have only received the treatment for relapses. Therapy Yes, currently Yes, in the past but not now FDA- approved MS disease modifying therapies: No Aubagio (teriflunomide) Avonex (interferon beta- 1a) Betaseron (interferon beta- 1b) Copaxone (glatiramer acetate) Extavia (interferon beta- 1b) Gilenya (fingolimod) Novantrone (mitoxantrone) Plegridy (peginterferon beta- 1a) Rebif (interferon beta- 1a) Tecfidera (dimethyl fumarate) Tysabri (natalizumab) Therapies that suppress/modulate the immune system: Campath (alemtuzumab) CellCept (mycophenolate mofetil) Cytoxan (cyclophosphamide) Imuran (azathioprine) Leustatin (cladribine) Myfortic (mycophenolate sodium) Rituxan (rituximab) Trexall (methotrexate) Zenapax (dacliximab, daclizumab) MS relapse treatments that are also used as disease- modifying therapies: (Do not select therapies that you've used only to treat relapses; only select those that you have used on a long- term basis to manage your MS) Acthar (adrenocorticotropic hormone) Decadron (dexamethasone) IVIG (immunoglobulin) Methylprednisone (methylprednisolone), Prednisone, Solu- Medrol (methylprednisolone sodium

succinate) Other: Low- dose Naltrexone Other